Mitogenic activity has been observed in FGF19 transgenic mice, which developed hepatocellular carcinoma within 12 months and showed increased hepatocyte proliferation as early as 2 to 4 months of age [24]. Here, FGF19 is linked to hepatocellular carcinoma.